关键信息
-
基因名
Lire1
- 应用
-
别名
(L1-ORF1p)(LINE retrotransposable element 1)(LINE1 retrotransposable element 1)(Transposase element L1Md-A101/L1Md-A102/L1Md-A2)
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P11260
-
表达区间
1-357aa
-
分子量
48.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
Lire1 is a protein that belongs to the family of immune receptors, specifically identified as an innate immune receptor involved in the recognition of specific ligands. This protein has garnered attention in recent years due to its role in the immune response and its potential implications in various diseases, including autoimmune disorders and infections. Research on Lire1 has focused on its structure-function relationship, elucidating the molecular mechanisms through which it interacts with ligands and triggers downstream signaling pathways. Understanding the functional dynamics of Lire1 can provide insights into how the immune system distinguishes between self and non-self, ultimately leading to novel therapeutic strategies for modulating immune responses. Additionally, the potential of Lire1 as a biomarker for disease progression and prognosis has sparked interest in its utility for clinical applications. Ongoing studies aim to explore the regulation of Lire1 expression and its interaction with other molecular partners, further establishing its importance in both basic and translational research within immunology.
